AEGLEA BIOTHERAPEUTICS INC's ticker is AGLE and the CUSIP is 00773J103. A total of 33 filers reported holding AEGLEA BIOTHERAPEUTICS INC in Q2 2017. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2023 | $111 | +56.3% | 245,678 | 0.0% | 0.04% | +59.3% |
Q1 2023 | $71 | -36.0% | 245,678 | 0.0% | 0.03% | -35.7% |
Q4 2022 | $111 | -99.9% | 245,678 | 0.0% | 0.04% | -12.5% |
Q3 2022 | $129,000 | +4.0% | 245,678 | 0.0% | 0.05% | -11.1% |
Q2 2022 | $124,000 | -78.1% | 245,678 | 0.0% | 0.05% | -81.4% |
Q1 2022 | $565,000 | -51.6% | 245,678 | 0.0% | 0.29% | -45.1% |
Q4 2021 | $1,167,000 | -40.2% | 245,678 | 0.0% | 0.53% | -52.5% |
Q3 2021 | $1,953,000 | +4.1% | 245,678 | -8.9% | 1.12% | -22.4% |
Q2 2021 | $1,876,000 | -15.3% | 269,578 | -3.6% | 1.44% | +10.7% |
Q1 2021 | $2,215,000 | +0.6% | 279,678 | 0.0% | 1.30% | -45.4% |
Q4 2020 | $2,201,000 | +11.0% | 279,678 | 0.0% | 2.38% | +15.5% |
Q3 2020 | $1,983,000 | -23.3% | 279,678 | 0.0% | 2.06% | -79.4% |
Q2 2020 | $2,587,000 | +72.0% | 279,678 | -13.3% | 10.00% | +382.1% |
Q1 2020 | $1,504,000 | -39.0% | 322,658 | 0.0% | 2.08% | -21.2% |
Q4 2019 | $2,465,000 | +7.3% | 322,658 | -3.8% | 2.63% | -7.4% |
Q2 2019 | $2,297,000 | -14.9% | 335,279 | 0.0% | 2.84% | -17.2% |
Q1 2019 | $2,699,000 | +7.5% | 335,279 | 0.0% | 3.43% | +26.6% |
Q4 2018 | $2,511,000 | -21.8% | 335,279 | 0.0% | 2.71% | -31.6% |
Q3 2018 | $3,209,000 | -11.0% | 335,279 | -1.6% | 3.97% | +185.7% |
Q2 2018 | $3,604,000 | -30.8% | 340,679 | -35.1% | 1.39% | -32.4% |
Q1 2018 | $5,207,000 | +83.3% | 524,929 | 0.0% | 2.05% | -81.3% |
Q4 2017 | $2,840,000 | +9.7% | 524,929 | 0.0% | 10.96% | +76.9% |
Q3 2017 | $2,588,000 | +28.1% | 524,929 | 0.0% | 6.20% | +3.2% |
Q2 2017 | $2,021,000 | -48.3% | 524,929 | 0.0% | 6.01% | -41.2% |
Q1 2017 | $3,911,000 | +71.3% | 524,929 | 0.0% | 10.21% | +56.0% |
Q4 2016 | $2,283,000 | -32.2% | 524,929 | 0.0% | 6.55% | -27.0% |
Q3 2016 | $3,365,000 | – | 524,929 | – | 8.97% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
UNIVERSITY OF TEXAS/TEXAS AM INVESTMENT MANAGEMENT CO | 279,678 | $2,587,000 | 10.00% |
Aisling Capital Management LP | 1,691,151 | $15,643,000 | 5.97% |
Samsara BioCapital, LLC | 967,500 | $8,949,000 | 2.88% |
Bain Capital Life Sciences Investors, LLC | 2,700,000 | $24,975,000 | 2.62% |
Soleus Capital Management, L.P. | 369,852 | $3,421,000 | 1.95% |
Nantahala Capital Management | 3,204,830 | $29,645,000 | 0.89% |
Lion Point Capital, LP | 300,000 | $2,775,000 | 0.67% |
Abingworth LLP | 240,500 | $2,221,000 | 0.62% |
Sio Capital Management, LLC | 211,104 | $1,953,000 | 0.57% |
Orbimed Advisors | 4,015,524 | $37,144,000 | 0.52% |